Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Botella

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
International Journal of Dermatology|January 17, 2024
Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort studyMiguel A Lasheras-Pérez, Rodolfo D Palacios-Diaz, Víctor A González-Delgado, et al.
International Journal of Dermatology|April 12, 2026
Improving Risk Stratification for SLNB in Elderly Patients With Melanoma: The SENTINOLD NomogramNieves Martínez Campayo, Sabela Paradela de la Morena, Sebastian Podlipnik, et al.
Dermatology and Therapy|August 27, 2025
Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete ResponseMiguel Mansilla-Polo, Carmen García-Moronta, Pablo Fernández-Crehuet, et al.
The Australasian Journal of Dermatology|June 19, 2024
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational studyMiguel Mansilla-Polo, Martí Pons-Benavent, Pablo Fernández-Crehuet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2025
Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched studyLía Bejarano, Mercè Grau-Pérez, Marina Paíno-Román, et al.
Journal of the American Academy of Dermatology|March 28, 2020
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) RegistryEsteban Daudén, Gregorio Carretero, Raquel Rivera, et al.
Acta Dermato-Venereologica|December 3, 2020
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective CohortCarlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, et al.
Journal of the American Academy of Dermatology|March 12, 2023
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort studyIgnasi Marti-Marti, Sebastian Podlipnik, Javier Cañueto, et al.
Journal of the American Academy of Dermatology|October 30, 2020
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysisOfelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, Raquel Rivera, et al.
Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
International Journal of Dermatology|January 17, 2024
Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort studyMiguel A Lasheras-Pérez, Rodolfo D Palacios-Diaz, Víctor A González-Delgado, et al.
International Journal of Dermatology|April 12, 2026
Improving Risk Stratification for SLNB in Elderly Patients With Melanoma: The SENTINOLD NomogramNieves Martínez Campayo, Sabela Paradela de la Morena, Sebastian Podlipnik, et al.
Dermatology and Therapy|August 27, 2025
Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete ResponseMiguel Mansilla-Polo, Carmen García-Moronta, Pablo Fernández-Crehuet, et al.
The Australasian Journal of Dermatology|June 19, 2024
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational studyMiguel Mansilla-Polo, Martí Pons-Benavent, Pablo Fernández-Crehuet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2025
Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched studyLía Bejarano, Mercè Grau-Pérez, Marina Paíno-Román, et al.
Journal of the American Academy of Dermatology|March 28, 2020
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) RegistryEsteban Daudén, Gregorio Carretero, Raquel Rivera, et al.
Acta Dermato-Venereologica|December 3, 2020
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective CohortCarlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, et al.
Journal of the American Academy of Dermatology|March 12, 2023
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort studyIgnasi Marti-Marti, Sebastian Podlipnik, Javier Cañueto, et al.
Journal of the American Academy of Dermatology|October 30, 2020
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysisOfelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, Raquel Rivera, et al.
Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Pageof 21